Management of the Elderly OAB Patient: What is the Evidence for Anticholinergic Burden?
Clinical Update
  • Home
  • Introduction (1:51 minutes)
  • Characteristics of the Ageing Population (5:17 minutes)
  • Urinary Incontinence and Overactive Bladder (10:32 minutes)
  • Management of OAB
    (7:29 minutes)
  • Overview of OAB Therapies (4:06 minutes)
  • Anticholinergic Burden in OAB Patients (16:13 minutes)
  • Program Evaluation
PFZ_039 Banner
Sender Herschorn, MD, FRCSC
Professor of Surgery/Urology,
University of Toronto
Attending Urologist,
Sunnybrook Health Sciences Centre

Linking Learning
This modular program contains a series of reflective questions for each section. You may wish to use these questions as a basis for a Linking Learning exercise. To learn more about this, click here.
Learning Objectives
At the conclusion of this activity, participants will be able to:
  • Recognize the specific health needs of their ageing patients relative to urinary incontinence (UI) and overactive bladder (OAB);
  • Describe behavioural interventions and different medical therapies for the management of OAB;
  • Interpret the association between anticholinergic therapies, cognitive impairment and dementia in ageing patients;
  • Evaluate the benefits vs. risks of long-term use of antimuscarinics in their
    elderly patients.
Under the guidance of the Innovative Medicines Canada Code of Conduct, this program is for healthcare professionals only. This learning program was supported by a grant from Pfizer Canada Inc.

Thank you for submitting the program evaluation.

  • Management of the elderly OAB patient: what is the evidence for anticholinergic burden?

    Program Evaluation:

  • Max number of characters 500
  • Yes
    Max number of characters 500
  • Yes
    Max number of characters 500
  • Yes
    Max number of characters 500
  • Max number of characters 500
  • Max number of characters 500
  • Yes No
    Max number of characters 500
  • Max number of characters 500
The information and opinions contained herein reflect the views and experience of the author and not necessarily those of the sponsor or STA Communications Inc. It is recommended that physicians evaluate their patient’s individual conditions before making a diagnosis or treatment decision. Any products mentioned herein should be used in accordance with the prescribing information contained in their respective product monographs. The content on this site is intended for health professionals. Copyright 2019 STA Communications Inc. All rights reserved. Content on this site may not be reproduced without explicit consent from the sponsor and STA Communications Inc. Terms and Conditions | Privacy Policy